N-tert.Butylbenzamidoxim | 20002-26-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-tert.Butylbenzamidoxim
• 英文别名: N'-tert-butyl-N-hydroxybenzenecarboximidamide
• CAS: 20002-26-0
• 化学式: C₁₁H₁₆N₂O
• 分子量: 192.261
• InChiKey: DZMWQPYECYFOAP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  44.6
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N-tert.Butylbenzamidoxim 在 氯化亚砜 、 三乙胺 作用下， 生成 N-((tert-butylimino)methylene)aniline
  参考文献：
  名称：

  Synthesis of 1,2,3,5-oxathiadiazole 2-oxides from amidoximes and thionyl chloride and the mechanism of their thermally induced fragmentation and rearrangement to carbodiimides

  摘要：

  DOI：

  10.1021/jo00441a011
• 作为产物：
  描述：

  N-tert.Butylbenzamidine hydrochloride 在 phosphate buffer 、 氧气 、 还原型辅酶II(NADPH)四钠盐 作用下， 反应 0.5h， 生成 N-tert.Butylbenzamidoxim
  参考文献：
  名称：

  N-叔烷基取代苯甲脒的体外N-氧化研究

  摘要：

  已经合成并表征了底物 N-叔丁基和 N-叔辛基苯甲脒 1a 和 b 以及它们可能的 N-氧化代谢物脒2a 和 b。N-叔。通过在 NADPH 存在下与未诱导的兔肝脏匀浆的微粒体部分有氧孵育，丁基苯甲脒 1a 被 N-氧化为相应的偕胺肟 2a。这种转换支持了这样的假设，即当由于脒氮的 α-位缺乏氢原子而无法进行 N-脱烷基化时，苯甲脒会通过细胞色素 P-450 酶系统进行 N-氧化。

  DOI：

  10.1002/ardp.19873200717

文献信息

• Easy Access to 1-Amino and 1-Carbon Substituted Isoquinolines <i>via</i> Cobalt-Catalyzed CH/NO Bond Activation
  作者：Krishnamoorthy Muralirajan、Ramajayam Kuppusamy、Sekar Prakash、Chien-Hong Cheng

  DOI：10.1002/adsc.201501056

  日期：2016.3.3

  A green atom‐economical method for the synthesis of highly functionalized 1‐amino and 1‐carbon substituted isoquinolines from the reaction of N′‐hydroxybenzimidamides and aryl ketoximes, respectively, with alkynes via pentamethylcyclopentadienylcobalt(III)‐catalyzed CH/NO bond activation is described. The external oxidant‐free annulation reaction uses the =NOH moiety in N′‐hydroxybenzimidamides or

  用于从反应高度官能化的1-氨基和1-碳取代的异喹啉的合成绿色原子的经济的方法N'- hydroxybenzimidamides和芳基酮肟，分别与炔烃经由pentamethylcyclopentadienylcobalt（III）催化Ç  H /Ñ 描述了O键活化。外部无氧化剂环化反应在N'-羟基苯甲酰胺或N中使用= NOH部分-芳族酮肟为导向基团和内部氧化剂。该第一行过渡金属催化的环化反应可作为异喹啉合成的有效替代方法，因为水是唯一的副产物，且贵金属例如铑（III），铱（III），钯（II）和钌是贵金属（II）不是必需的。反应的进行通过Ç  ħ活化，炔插入，还原消除，和N  Ò活化。
• Novel n(phenylsulphonyl)glycine derivatives and their therapeutic use
  申请人：——

  公开号：US20040063725A1

  公开（公告）日：2004-04-01

  The present invention relates to novel N-(phenylsulphonyl)glycyl-glycine compounds, which are defined by formula I and the description, as well as their method of preparation and their use in therapeutics 1

  本发明涉及一种新颖的N-(苯磺酰基)甘氨酰甘氨酸化合物，其由式I和描述所定义，以及它们的制备方法及在治疗中的用途。
• Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
  申请人：Biorex Research & Development Co.

  公开号：US06653326B1

  公开（公告）日：2003-11-25

  A method of increasing expression of a molecular chaperon by a cell and/or enhancing the activity of a molecular chaperon in cells is provided. The method comprises treating a cell that is exposed to a physiological stress which induces expression of a molecular chaperon by the cell with an effective amount of a certain hydroxylamine derivative to increase the stress. Alternatively; an hydroxylamine derivative can be administrated to a cell before it is exposed to a physiological stress which induces expression of a molecular chaperon by the cell. Preferably, the cell to which an hydroxylamine derivative is administered is an eukaryotic cell. The hydroxylamine derivative corresponds to the formulae (I) or (II). The invention also provides novel hydroxyl amine derivatives falling within the scope of the formulae (I) and (II) as well as pharmaceutical and/or cosmetical compositions comprising the said compounds.

  提供了一种通过细胞增加分子伴侣的表达和/或增强细胞中分子伴侣活性的方法。该方法包括将暴露于诱导细胞表达分子伴侣的生理应激的细胞用有效量的某种羟胺衍生物进行处理，以增加应激。或者；可以在细胞暴露于诱导细胞表达分子伴侣的生理应激之前向细胞施加羟胺衍生物。最好，施加羟胺衍生物的细胞是真核细胞。羟胺衍生物对应于式（I）或（II）。本发明还提供了新颖的羟胺衍生物，属于式（I）和（II）范围内，以及包含所述化合物的药用和/或化妆品组合物。
• Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof
  申请人：Biorex Research & Development Co.

  公开号：US20040067940A1

  公开（公告）日：2004-04-08

  A method of increasing expression of a molecular chaperon by a cell and/or enhancing the activity of a molecular chaperon in cells is provided. The method comprises treating a cell that is exposed to a physiological stress which induces expression of a molecular chaperon by the cell with an effective amount of a certain hydroxylamine derivative to increase the stress. Alternatively, an hydroxylamine derivative can be administrated to a cell before it is exposed to a physiological stress which induces expression of a molecular chaperon by the cell. Preferably, the cell to which an hydroxylamine derivative is administered is an eukaryotic cell. The hydroxylamine derivative corresponds to the formulae (I) or (II). The invention also provides novel hydroxylamine derivatives falling within the scope of the formulae (I) and (II) as well as pharmaceutical and/or cosmetical compositions comprising the said compounds.

  提供了一种通过细胞增加分子伴侣表达和/或增强细胞中分子伴侣活性的方法。该方法包括使用一定量的某种羟胺衍生物处理受到诱导细胞分子伴侣表达的生理应激的细胞，以增加应激。或者，在细胞暴露于诱导其表达分子伴侣的生理应激之前，可以向细胞施用羟胺衍生物。最好，施用羟胺衍生物的细胞是真核细胞。羟胺衍生物对应于式(I)或(II)。该发明还提供了落在式(I)和(II)范围内的新羟胺衍生物，以及包含上述化合物的药物和/或化妆品组合物。
• METHOD OF ENHANCING CELLULAR PRODUCTION OF MOLECULAR CHAPERONE, HYDROXYLAMINE DERIVATIVES USEFUL FOR ENHANCING THE CHAPERONE PRODUCTION AND THE PREPARATION THEREOF
  申请人：Vígh László

  公开号：US20100267711A1

  公开（公告）日：2010-10-21

  A method of increasing expression of a molecular chaperon by a cell and/or enhancing the activity of a molecular chaperon in cells is provided. The method comprises treating a cell that is exposed to a physiological stress which induces expression of a molecular chaperon by the cell with an effective amount of a certain hydroxylamine derivative to increase the stress. Alternatively, an hydroxylamine derivative can be administrated to a cell before it is exposed to a physiological stress which induces expression of a molecular chaperon by the cell. Preferably, the cell to which an hydroxylamine derivative is administered is an eukaryotic cell. The hydroxylamine derivative corresponds to the formulae (I) or (II). The invention also provides novel hydroxylamine derivatives falling within the scope of the formulae (I) and (II) as well as pharmaceutical and/or cosmetical compositions comprising the said compounds.

  本发明提供了一种通过细胞增加分子伴侣的表达和/或增强细胞中分子伴侣活性的方法。该方法包括使用一定量的某种羟胺衍生物处理受到诱导细胞分子伴侣表达的生理应激的细胞，以增加应激。或者，在细胞暴露于诱导其表达分子伴侣的生理应激之前，可以向细胞中注入羟胺衍生物。最好，接受羟胺衍生物处理的细胞是真核细胞。羟胺衍生物对应于公式（I）或（II）。本发明还提供了落在公式（I）和（II）范围内的新羟胺衍生物，以及包含该化合物的药物和/或化妆品组合物。